293. Ludvigsson JF, Bai JC, Biagi F, et al. Diagnosis and Management of Adult Coeliac Disease. Guidelines from the British Society of Gastroenterology. Gut. 2014;63(8):1210–1228
294. Cristofori F, Fontana C, Magista A, et al. Increased prevalence of celiac disease among pediatric patients with irritable bowel syndrome. A 6-year prospective chort study. JAMA Pediatr 2014. doi:10.1001/jamapediatrics.2013.4984
295. Carroccio A, Mansueto P, Iacono G, et al. Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: Exploring a new clinical entity. Am J Gastroenterol, 24 July 2012. doi:10.1038/ajg.2012.236
296. Lundin KEA, Farstad IN, Sollid LM. Cøliaki – nye kliniske erkjennelser og diagnostiske hjelpemidler. Tidsskr Nor Lægeforen 2003; 123: 3226–9
297. Green PH, Shane E, Rotterdam H, Forde KA, Grossbard L. Significance of unsuspected celiac disease detected at endoscopy. Gastrointest Endosc 2000; 51: 60–65
298. Tursi A, Giorgetti G, Brandimarte G, Rubino E, Lombardi D, Gasbarrini G. Prevalence and clinical presentation of subclinical/silent celiac disease in adults: an analysis on a 12-year observation. Hepatogastroenterology 2001; 48: 462–64
299. Green PHR, Stavropoulos SN, Panagi SG, et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol 2001; 96: 126–31
300. Collin P, Reunala T, Rasmussen M, et al. High incidence and prevalence of adult coeliac disease: augmented diagnostic approach. Scand J Gastroenterol 1997; 32: 1129–33
301. Lo W, Sano K, Lebwohl B, Diamond B, Green PHR. Changing presentation of celiac disease. Dig Dis Sci 2003; 48: 395–98
302. Shah VH, Rotterdam H, Kotler DP, Fasano A, Green PH. All that scallops is not celiac disease. Gastrointest Endosc 2000; 51: 717–20
303. Katz KD, Rashtak S, Lahr BD, et al. Screening for celiac disease in a North American Population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol 2011; 106: 1333–9
304. Pastore L, Carroccio A, Compilato D, et al. Oral manifestations of celiac disease. J Clin Gastroenterol. 2008;42:224–232
305. Bodvarsson S, Jonsdottir I, Freysdottir J, Leonard JN, Fry L, Valdimarsson T. Dermatitis herpetiformis: an autoimmune disease due to cross-reaction between dietary glutenin and dermal elastin. Scand J Immunol 1993; 38: 546–50
306. Hadjivassiliou M, Sanders DS, Grünewald RA, et al. Gluten sensitivity: from gut to brain. Lancet Neurol 2010; 9: 318–30
307. Leonard JN, Tucker WF, Fry JS, et al. Increased incidence of malignancy in dermatitis herpetiformis. BMJ 1983; 286 (Clin Res Ed): 16–18
308. Rostom A, Dubé C, Cranney A, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005; 128 (4 Suppl 1): 38–46
309. Rumessen JJ. Serologisk screening for cøliaki. Ugeskr Læger 2004; 166: 2142–4
310. Sategna-Guidetti C, Pulitano R, Grosso S, Ferfoglia G. Serum IgA antiendomysium antibody titers as a marker of intestinal involvement and diet compliance in adult celiac sprue. J Clin Gastroenterol 1993; 17: 123–27
311. Mäki M, Mustalahti K, Kokkonen J, et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003;348:2517–2524
312. Fasano A. European and North American populations should be screened for coeliac disease. Gut 2003; 152: 168–9
313. Valdimarsson T, Toss G, Ross I, Lofman O, Strom M. Bone mineral density in coeliac disease. Scand J Gastroenterol 1994; 29: 457–61
314. Scotta MS, Salvatore S, Salvatoni A, et al. Bone mineralization and body composition in young patients with celiac disease. Am J Gastroenterol 1997; 92: 1331–34
315. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology 1992; 102: 330–54
316. Garsed K, Scott BB. Can oats be taken in a gluten-free diet? A systematic review. Scand J Gastroenterol 2007; 42: 171–8
317. Løvik A, Lundin KEA. «Kostbehandling av cøliaki og dermatitis herpetiformis». Tidsskr Nor Lægeforen 2003; 123: 3237–40
318. Johnson D. Novel Drug for Celiac Disease Reduces GI and Non-GI Symptoms. Digestive Disease Week (DDW) 2014. Abstract 929f. Presented May 7, 2014. http://www.medscape.com/viewarticle/824778?sr…
319. Castillo NE, Theethira TG, Leffler DA. The present and the future in the diagnosis and management of celiac disease. Gastroenterol. Rep. (2015) 3 (1): 3–11
320. Ilus T, Kaukinen K, Virta LJ, et al. Incidence of malignancies in diagnosed celiac patients. Am J Gastroenterol 2014; 109(9): 1471–77
321. Fickling WE, McFarlane XA, Bhalla AK, Robertson DAF. The clinical impact of metabolic bone disease in coeliac disease. Postgrad Med 2001; 77: 33–6
322. Farthing MJ, Edwards CR, Rees LH, Dawson AM. Male gonadal function in coeliac disease: 1 sexual dysfunction, infertility, and semen quality. Gut 1982; 23: 608–14
323. Thawani SP, Brannagan TH, Lebwohl B, et al. Risk of neuropathy among 28 232 patients with biopsy-verified Celiac disease. JAMA Neurology 2015. doi:10.1001/jamaneurol. 2015.0475
324. Evans KE, Leeds JS, Morley S et.al. Pancreatic insufficiency in adult celiac disease: do patients require long-term enzyme supplementation? Dig Dis Sci 2010; 55: 2999–3004
325. Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A. Coeliac disease-associated disorders and survival. Gut 1994; 35: 1215–18
326. Corrao G, Corazza GR, Bagnardi V, et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001; 358: 356–61
327. Peters U, Askling J, Gridley G, Ekbom A, Linet M. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 2003; 163: 1566–72
328. Sultan AA, Tata LJ, Fleming KM, et al. Pregnancy complications and adverse birth outcomes among women with celiac disease. Am J Gastroenterol. 2014;109:1653–1661
329. Fagrådet i Norsk Cøliakiforening. Retningslinjer – cøliaki. 2004
330. Vanuytsel, T; et al. The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease. Tissue Barriers 2013. 1 (5): e27321
331. Fasano, A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011 91 (1): 151–75
332. Lammers, Karen M.; Lu, Ruliang; Brownley, Julie; Lu, Bao; Gerard, Craig; Thomas, Karen; Rallabhandi, Prasad; Shea-Donohue, Terez; Tamiz, Amir. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 2008. 135 (1): 194–204.e3
